India’s neighbourhood medical stores are the country’s most widely used access point for medicines, but a nationwide consumer survey suggests that prescription checks, qualified pharmacist assistance and transaction records remain inconsistent. The findings have gained significance as the Union Ministry of Health and Family Welfare proposes mandatory CCTV surveillance at medical stores dispensing prescription medicines.
The proposal attempts to address a problem that is difficult to solve through rules alone: prescription drugs are sold through a large, dispersed retail network that consumers use every day. Unlike a small number of large hospitals or organised pharmacy chains, neighbourhood chemists are embedded in local streets and markets across cities and smaller towns. Their proximity makes them essential to medicine access, but also makes routine enforcement and documentation more difficult.
The LocalCircles survey received about 1.06 lakh responses from consumers across 327 districts. The respondents included 63% men and 37% women. In terms of location, 52% were from tier-1 districts, 29% from tier-2 districts and 29% from tier-3, 4 and 5 districts, according to the report published by The Hindu.
The most significant finding concerns the sale of prescription medicines. Sixty-four per cent of consumers said their chemist never or rarely asked for a doctor’s prescription before selling medicines during the previous 12 months. Only 15% said their chemist mostly or always refused to sell medicines without a prescription. The survey does not establish how many individual transactions involved a breach, but it indicates that consumers frequently encounter weak or absent prescription checks.
That pattern matters because the neighbourhood chemist is not a marginal part of the medicine supply system. Of 16,822 respondents who answered how they had primarily purchased medicines in the previous 12 months, 86% said they primarily depended on local chemists. Fourteen per cent primarily used ePharmacy applications. The figures position local medical stores as a critical piece of everyday urban service infrastructure, particularly for consumers seeking medicines close to home.
The survey also points to a gap between the presence of a medical store and the availability of qualified assistance within it. Of 19,409 respondents asked about help with medicines or disease-related queries, only 31% said they were able to receive assistance from a qualified pharmacist most of the time or always. Twenty-seven per cent said they never or very rarely received such assistance, while 13% said they were assisted by someone who was not a qualified pharmacist.
This distinction is central to the enforcement problem. A medical store may be physically accessible, but access does not necessarily mean that consumers are receiving advice from the professional responsible for dispensing medicines. The survey findings, as reported, do not identify the reasons for the absence of qualified assistance in particular stores. They do, however, show that consumers do not consistently experience the pharmacist-led service that regulation is expected to support.
The proposed CCTV requirement is designed to make prescription-medicine sales traceable. The draft notification floated by the Union Ministry of Health and Family Welfare would require the supply, other than by wholesale, of any drug sold on the prescription of a Registered Medical Practitioner to take place under a CCTV surveillance system installed and maintained at the premises.
In administrative terms, surveillance would create a record of activity at the point of sale. That could help enforcement agencies examine whether prescription medicines were supplied and whether the premises was operating within the proposed conditions. But the proposal, as described in the report, is principally a traceability measure. The supplied material does not establish how long recordings would be retained, who would access them, how inspections would be triggered or what penalties would apply when a breach is identified.
Those implementation details are important because the survey describes a system with several different compliance problems. The issue is not limited to whether a prescription is shown. The report also refers to intensified enforcement in multiple States against chemists selling prescription medicines without valid prescriptions, operating without registered pharmacists and failing to provide proper bills. CCTV may document a transaction, but it cannot by itself ensure that a registered pharmacist is present, that a prescription is valid or that the medicine supplied is appropriate.
Home delivery adds another layer to the same challenge. Among 15,473 respondents who answered questions about medicine deliveries, 41% said a prescription was never or rarely requested during home delivery. The survey does not specify whether all of these deliveries involved medicines for which a prescription was legally required. It does indicate, however, that the move from a physical shop counter to a delivery transaction may create another point at which prescription verification becomes inconsistent.
Billing is similarly connected to accountability. Of 20,573 respondents, 26% said they were not provided a GST bill when buying medicines from local chemists. The survey report described a bill as more than a tax document because it carries the batch number, expiry date and identity of the seller, creating a record if a medicine is expired, defective or counterfeit. Without that record, a consumer may find it more difficult to identify the seller or trace the product after a problem.
The findings on counterfeit or ineffective medicines are especially serious, although they must be read as consumer responses rather than an independently verified count of counterfeit products. Of 18,457 respondents, 15% said they had bought medicines that were later found to be fake or counterfeit. The supplied report does not explain how respondents determined that a product was counterfeit or ineffective, nor does it provide a laboratory or enforcement breakdown. The number therefore signals a substantial consumer concern, but does not by itself establish the scale of counterfeit medicine circulation.
The governance challenge is that medicine safety is being managed at the intersection of national rules and highly localised retail practice. The Union Ministry is proposing the draft CCTV requirement, while enforcement action against medical stores is being intensified across multiple States. The stores themselves operate at neighbourhood level, where consumers may return repeatedly to the same chemist and where transactions can take place outside the formal visibility of large health institutions.
This makes documentation a crucial link between regulation and enforcement. Prescription records, bills, pharmacist credentials and surveillance footage would each capture a different part of a transaction. The survey suggests that consumers do not consistently encounter these safeguards. Yet the available material does not show whether the proposed system would integrate these records, how smaller stores would bear the compliance cost or whether enforcement agencies have the capacity to review the resulting data.
The evidence also shows why a single intervention is unlikely to describe the entire problem. Local chemists are the primary medicine source for 86% of respondents who answered that question. At the same time, only 31% consistently or mostly received assistance from a qualified pharmacist, 41% rarely or never faced prescription checks during home delivery, and 26% reported not receiving GST bills. These figures relate to different survey questions and respondent groups, so they should not be treated as a single connected transaction profile. Together, however, they show multiple points at which consumer protection can weaken.
The proposed surveillance requirement therefore turns a familiar neighbourhood retail practice into a question of institutional visibility. If the sale of prescription medicines is recorded, authorities may have a stronger basis for investigating complaints and identifying repeat non-compliance. But the reported proposal does not yet answer how surveillance would be linked to inspections, licensing, pharmacist registration, billing requirements or product verification. Those details will determine whether CCTV becomes an enforceable compliance tool or simply another requirement placed on store premises.
The survey does not establish that every medical store ignores prescription rules, lacks qualified pharmacists or sells unsafe products. It does show that a large share of consumers report encountering weak safeguards in a service they depend on heavily. The next stage is the draft notification and the enforcement framework that accompanies it. The questions to monitor are whether the proposal becomes mandatory, what technical and retention standards it sets, how authorities will inspect compliance, and how prescription, billing and pharmacist requirements will be enforced together.
